Research and development for biocompatibility testing, animal studies, and sterilization testing in the blueprint medtech (bpmt) initiative - kickoff meetings
Ended Awarded Last action
- Contract number
- 75N95023F00001
- Awardee
-
Actuated Medical, Inc. UEI VG84D4KN5LR5
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,777
Award facts
- Opportunity
-
- Blueprint MedTech (BPMT) Biocompatibility, Sterilization, and Animal Studies Pre-Solicitation · Posted Jan 18, 2022
- Contract value 100% obligated
- $3,777.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Bellefonte, PA 16823, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$82 | |
| Original award | $3,859 |
About this award
The National Institute on Drug Abuse issued a $3,777.48 delivery order to Actuated Medical, Inc., a woman-owned small business, on September 20, 2023, for research and development supporting biocompatibility testing, animal studies, and sterilization testing in the Blueprint MedTech Initiative.
Work is performed in Bellefonte, PA. The order carries a cost-plus-fixed-fee pricing structure with an ultimate completion date of September 19, 2024. The delivery order was issued under Actuated Medical's $35 million single-award IDC with NIDA (through September 2028), which enables task orders for specialized research services including biocompatibility assessments, good laboratory practice animal testing, sterilization validation, and shelf life testing to de-risk development of medical technologies focused on nervous system disorders.
Quick answers
Who was awarded contract 75N95023F00001?
75N95023F00001 was awarded to Actuated Medical, Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 20, 2023.
How much is contract 75N95023F00001 worth?
The government has obligated $3,777 on 75N95023F00001.
Is contract 75N95023F00001 an order under another contract?
Yes. 75N95023F00001 is a delivery order under 75N95023D00022, an indefinite delivery contract.
Was contract 75N95023F00001 competed?
The extent of competition for 75N95023F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award